Cicor Technologies (CICN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
22 Jul, 2026Executive summary
Revenue grew 19% year-over-year to CHF 334.1 million, driven by acquisitions and a return to organic growth in Q2.
Order intake surged 39.8% to CHF 399.8 million, with a book-to-bill ratio of 1.2 for the fifth consecutive quarter.
Integration of 2025 acquisitions is largely complete, delivering operational synergies and expected recurring annual EBITDA improvements of over CHF 10 million.
Workforce reduced by 5% (220 employees) through site divestments and consolidation.
Aerospace & Defence segment saw exceptional growth, now representing 28% of total revenue.
Financial highlights
Adjusted EBITDA was CHF 28.0 million (margin 8.4%), down from CHF 29.0 million (10.3%) year-over-year due to integration costs and lower margins from acquisitions.
Adjusted EBIT reached CHF 19.1 million (margin 5.7%), compared to CHF 21.4 million (7.6%) in H1 2025.
Adjusted net profit was CHF 12.2 million, with adjusted EPS at CHF 2.76, both slightly below prior year.
Free cash flow before M&A was CHF -11.5 million, impacted by higher net working capital and inventory build-up.
Net debt increased to CHF 82.6 million, with financial leverage at 1.34x adjusted EBITDA.
Outlook and guidance
Sequential revenue growth of 10–25% expected from H1 to H2, with full-year 2026 guidance confirmed: revenue CHF 700–750 million and adjusted EBITDA CHF 70–80 million.
Growth in H2 to be mostly organic, with supply chain execution as the main risk to achieving the upper end of guidance.
Robust double-digit adjusted EBITDA margin anticipated in H2 due to completed integration and efficiency measures.
Focus remains on converting working capital into cash and pursuing further acquisitions.
Latest events from Cicor Technologies
- Ambitious 2028 targets CHF 1B+ revenue via M&A, innovation, and operational excellence.CICN
CMD 2024 Presentation8 Jul 2026 - Achieved 28.2% sales growth in 2025 and targets CHF 700-750 million sales for 2026.CICN
Investor presentation11 May 2026 - Revenue up 28% to CHF 616.5–660m, five acquisitions, and strong 2026 outlook.CICN
Q4 20256 May 2026 - Q1 sales up 22.6% to CHF 160.7M, with strong A&D orders and positive 2026 outlook.CICN
Q1 202614 Apr 2026 - 2025 sales surged 28.2% to CHF 616.5 million, fueled by acquisitions and sector growth.CICN
Investor presentation26 Mar 2026 - Net profit rose 53.9% as acquisitions drove record sales and upgraded guidance.CICN
H1 20243 Feb 2026 - Transformational acquisition forms the largest global HMLV EMS provider, driving growth and synergies.CICN
M&A Announcement (Media)11 Dec 2025 - Record sales, profit, and cash flow in 2024 set the stage for continued growth in 2025.CICN
H2 20241 Dec 2025 - Sales up 21.4% year-over-year, guidance raised on strong M&A and Q2 organic growth.CICN
H1 202516 Nov 2025